# Safranal-Standardized Saffron Extract Improves Metabolic, Cognitive, and Anxiolytic Outcomes in Aged Mice via Hypothalamic–Amygdalar Peptide Modulation

**Authors:** Juan A. Navarro, Ana Gavito, Sonia Rivas, Alonso Rodríguez-Martín, Elena Baixeras, Juan Decara, Pedro J. Serrano-Castro, Yolanda Alfonso, Carlos Sanjuan, Antonia Serrano, Fernando Rodríguez de Fonseca

PMC · DOI: 10.3390/nu18020291 · 2026-01-16

## TL;DR

A standardized saffron extract improves memory, reduces anxiety, and supports metabolism in old mice by affecting brain peptides.

## Contribution

Demonstrates that standardized saffron extract has multi-target effects on aging-related conditions in mice.

## Key findings

- Low-dose saffron extract prevents age-related weight loss and modulates liver lipid metabolism.
- High-dose saffron extract reduces anxiety and improves memory in aged mice.
- Saffron extract alters brain peptides linked to anxiety and memory, such as Npy, Crh, and Hcrt.

## Abstract

Background: Population aging increases susceptibility to cognitive decline, anxiety, and metabolic dysregulation, yet safe and effective interventions remain limited. Saffron (Crocus sativus L.) has been traditionally used to enhance mood and cognition, and its main metabolites, crocins and safranal, exert neuroprotective, anxiolytic, and metabolic effects. However, variability in extract composition and frequent adulteration hinder reproducibility. Objectives: To clarify the efficacy of genuine saffron preparations in aging, we investigated a saffron extract standardized for safranal and crocin content (SSE). Methods: Safranal bioavailability was first characterized in rats, followed by an evaluation of behavioral, neuroendocrine, and metabolic outcomes after 35 days of oral SSE administration (25 or 200 mg/kg/day) in 25-month-old male C57BL/6 mice. Behavioral performance was assessed using open field and novel object recognition tests, while molecular analyses targeted neuropeptides in the hypothalamus and amygdala, hippocampal plasticity markers, cortical inflammatory proteins, and hepatic lipid metabolism genes. Results: SSE administration induced a rapid but transient increase in the plasma’s safranal, confirming its bioavailability. In aged mice, the low dose prevented age-related weight loss and modulated hepatic lipid metabolism, whereas the high dose reduced anxiety-like behavior and improved recognition memory. The anxiolytic effects are consistent with elevated hypothalamic Npy, an anxiolytic peptide, reduced amygdalar Crh, a key mediator of stress and anxiety, and decreased hypothalamic Hcrt, an arousal modulator. The improvement in memory is associated with modulation of the cortical and hippocampal inflammatory and endocannabinoid proteins involved in neural plasticity. Conclusions: These findings highlight content-standardized saffron extracts as a promising multi-target nutraceuticals for healthy aging.

## Linked entities

- **Proteins:** NPY (neuropeptide Y), CRH (corticotropin releasing hormone), HCRT (hypocretin neuropeptide precursor)
- **Chemicals:** safranal (PubChem CID 61041)

## Full-text entities

- **Diseases:** anxiety (MESH:D001007), inflammatory (MESH:D007249), cognitive decline (MESH:D003072), weight loss (MESH:D015431), metabolic dysregulation (MESH:D021081)
- **Chemicals:** Safranal (MESH:C087963), Npy (MESH:C065586), Amygdalar Peptide (-), crocin (MESH:C029036), endocannabinoid (MESH:D063388), lipid (MESH:D008055)
- **Species:** Crocus sativus (saffron crocus, species) [taxon 82528], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12845050/full.md

---
Source: https://tomesphere.com/paper/PMC12845050